Eddit
Zeile 22: | Zeile 22: | ||
*'''[[Innate sensing]]''' | *'''[[Innate sensing]]''' | ||
*'''[[Immunology]]''' | *'''[[Immunology]]''' | ||
− | + | {{tp|p=32348472|t=ä. A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients?|pdf=|usr=}} | |
Zeile 45: | Zeile 45: | ||
{{tp|p=32303472|t=ä. Acute pulmonary embolism in a patient with COVID-19 pneumonia |pdf=|usr=}} | {{tp|p=32303472|t=ä. Acute pulmonary embolism in a patient with COVID-19 pneumonia |pdf=|usr=}} | ||
{{tp|p=32348233|t=2020. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease |pdf=|usr=}} | {{tp|p=32348233|t=2020. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease |pdf=|usr=}} | ||
+ | {{tp|p=32227120|t=ä. Acute pulmonary embolism and COVID-19 pneumonia: a random association?|pdf=|usr=}} | ||
+ | {{tp|p=32338707|t=ä. Acute pulmonary embolism in conjunction with intramural right ventricular thrombus in a SARS-CoV-2-positive patient |pdf=|usr=}} | ||
+ | |||
*'''[[Hematology]]''' | *'''[[Hematology]]''' | ||
*'''[[Heart]]''' | *'''[[Heart]]''' | ||
+ | {{tp|p=32363381|t=ä. Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?|pdf=|usr=}} | ||
+ | {{tp|p=32227076|t=ä. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32196087|t=ä. SARS-CoV2: should inhibitors of the renin?angiotensin system be withdrawn in patients with COVID-19?|pdf=|usr=}} | ||
+ | {{tp|p=32267502|t=ä. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection |pdf=|usr=}} | ||
+ | {{tp|p=32267494|t=ä. CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32285920|t=ä. Transient complete heart block in a patient with critical COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32285915|t=ä. Typical takotsubo syndrome triggered by SARS-CoV-2 infection |pdf=|usr=}} | ||
+ | {{tp|p=32338706|t=ä. Myocarditis revealing COVID-19 infection in a young patient |pdf=|usr=}} | ||
+ | {{tp|p=32282027|t=ä. COVID-19-related myocarditis in a 21-year-old female patient |pdf=|usr=}} | ||
+ | |||
*'''[[Neurology, ophthalmology, orl]]''' | *'''[[Neurology, ophthalmology, orl]]''' | ||
Zeile 54: | Zeile 67: | ||
{{tp|p=32269598|t=2020. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?|pdf=|usr=}} | {{tp|p=32269598|t=2020. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?|pdf=|usr=}} | ||
{{tp|p=32370982|t=ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review |pdf=|usr=}} | {{tp|p=32370982|t=ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review |pdf=|usr=}} | ||
+ | {{tp|p=32253535|t=ä. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study |pdf=|usr=}} | ||
+ | {{tp|p=32328771|t=ä. The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32303881|t=ä. Possible link between anosmia and COVID-19: sniffing out the truth |pdf=|usr=}} | ||
*'''[[Dermatology]]''' | *'''[[Dermatology]]''' | ||
Zeile 68: | Zeile 84: | ||
*'''[[Pathobiology]]''' | *'''[[Pathobiology]]''' | ||
{{tp|p=32294179|t=ä. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications |pdf=|usr=}} | {{tp|p=32294179|t=ä. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications |pdf=|usr=}} | ||
− | + | {{tp|p=32293672|t=ä. Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts |pdf=|usr=}} | |
*'''[[Disease Models]]''' | *'''[[Disease Models]]''' | ||
Zeile 86: | Zeile 102: | ||
{{tp|p=32241244|t=2020. Diagnostic value and key features of computed tomography in Coronavirus Disease 2019 |pdf=|usr=}} | {{tp|p=32241244|t=2020. Diagnostic value and key features of computed tomography in Coronavirus Disease 2019 |pdf=|usr=}} | ||
{{tp|p=32285222|t=ä. Three unsuspected CT diagnoses of COVID-19 |pdf=|usr=}} | {{tp|p=32285222|t=ä. Three unsuspected CT diagnoses of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32285028|t=2020. Lung Changes on Chest CT During 2019 Novel Coronavirus (COVID-19) Pneumonia |pdf=|usr=}} | ||
+ | |||
+ | |||
Zeile 92: | Zeile 111: | ||
*'''[[Clinical guidelines and advice]]''' | *'''[[Clinical guidelines and advice]]''' | ||
+ | {{tp|p=32306118|t=ä. COVID-19 in otolaryngologist practice: a review of current knowledge |pdf=|usr=}} | ||
+ | {{tp|p=32352517|t=ä. Anticoagulation in COVID-19 |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Respiration mgmt]]''' | *'''[[Respiration mgmt]]''' | ||
{{tp|p=32371555|t=2020. Utility of extracorporeal membrane oxygenation in COVID-19 |pdf=|usr=}} | {{tp|p=32371555|t=2020. Utility of extracorporeal membrane oxygenation in COVID-19 |pdf=|usr=}} | ||
Zeile 97: | Zeile 120: | ||
{{tp|p=32326959|t=2020. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients |pdf=|usr=}} | {{tp|p=32326959|t=2020. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients |pdf=|usr=}} | ||
{{tp|p=C7156900|t=2020. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series |pdf=|usr=}} | {{tp|p=C7156900|t=2020. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series |pdf=|usr=}} | ||
+ | {{tp|p=32322959|t=ä. Tracheostomy in the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32314050|t=ä. Recommendation of a practical guideline for safe tracheostomy during the COVID-19 pandemic |pdf=|usr=}} | ||
+ | |||
*'''[[Risk and special populations]]''' | *'''[[Risk and special populations]]''' | ||
+ | {{tp|p=32232395|t=ä. Initial COVID-19 affecting cardiac patients in China |pdf=|usr=}} | ||
+ | {{tp|p=32324223|t=ä. Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence |pdf=|usr=}} | ||
+ | {{tp|p=32324222|t=ä. Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32236478|t=ä. Speculation is not evidence: antihypertensive therapy and COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32286607|t=ä. Might renin?angiotensin system blockers play a role in the COVID-19 pandemic?|pdf=|usr=}} | ||
+ | {{tp|p=32344292|t=2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors |pdf=|usr=}} | ||
+ | {{tp|p=32305831|t=ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment |pdf=|usr=}} | ||
*'''[[Case reports]]''' | *'''[[Case reports]]''' | ||
Zeile 119: | Zeile 152: | ||
*'''[[Candidate Compounds Covid19]]''' | *'''[[Candidate Compounds Covid19]]''' | ||
+ | {{tp|p=32363880|t=2020. Medical treatment options for COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32372695|t=2020. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol |pdf=|usr=}} | ||
+ | {{tp|p=32347925|t=ä. Statin therapy in COVID-19 infection |pdf=|usr=}} | ||
+ | {{tp|p=32347923|t=ä. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety |pdf=|usr=}} | ||
+ | {{tp|p=32337546|t=ä. Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?|pdf=|usr=}} | ||
+ | {{tp|p=32282032|t=ä. Neprilysin inhibitor?angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients |pdf=|usr=}} | ||
+ | |||
Zeile 133: | Zeile 173: | ||
{{tp|p=32324531|t=2020. The Practice of Wearing Surgical Masks during the COVID-19 Pandemic |pdf=|usr=}} | {{tp|p=32324531|t=2020. The Practice of Wearing Surgical Masks during the COVID-19 Pandemic |pdf=|usr=}} | ||
{{tp|p=32284092|t=2020. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols |pdf=|usr=}} | {{tp|p=32284092|t=2020. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols |pdf=|usr=}} | ||
+ | {{tp|p=32282025|t=ä. Donning and doffing of personal protective equipment (PPE) for angiography during the COVID-19 crisis |pdf=|usr=}} | ||
+ | |||
+ | |||
* | * | ||
*'''[[Running your hospital]]''' | *'''[[Running your hospital]]''' | ||
− | + | {{tp|p=32228737|t=ä. COVID-19 disease emergency operational instructions for Mental Health Departments issued by the Italian Society of Epidemiological Psychiatry |pdf=|usr=}} | |
+ | {{tp|p=32303485|t=ä. French consensus on management of head and neck cancer surgery during COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32338298|t=ä. The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32232396|t=ä. Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32361812|t=ä. Mental health treatment online during the COVID-19 outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32338764|t=ä. A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience |pdf=|usr=}} | ||
+ | {{tp|p=32286606|t=ä. Priorities for Cath labs in the COVID-19 tsunami: Roberto Ferrari and co-authors present a procedure to follow subsequent to the outbreak in Italy |pdf=|usr=}} | ||
+ | {{tp|p=32320040|t=ä. Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective |pdf=|usr=}} | ||
+ | {{tp|p=32242891|t=ä. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel |pdf=|usr=}} | ||
+ | {{tp|p=32285027|t=2020. Breast Cancer Diagnosis, Treatment and Follow-Up During COVID-19 Pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32285026|t=2020. Sars-CoV-2 (COVID-19) Outbreak and Breast Cancer Surgery in Turkey |pdf=|usr=}} | ||
+ | {{tp|p=32305011|t=2020. Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)?related disease pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32294611|t=2020. A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19?positive patients with cancer |pdf=|usr=}} | ||
*'''[[Mental aspects of health professionals]]''' | *'''[[Mental aspects of health professionals]]''' | ||
− | + | {{tp|p=32342698|t=ä. Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic |pdf=|usr=}} | |
*'''[[Socio-psychiatric aspects of the status hygienicus]]''' | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | ||
− | + | {{tp|p=32363492|t=ä. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19 |pdf=|usr=}} | |
*'''[[Avoiding clinical medicine in other diseases]]''' | *'''[[Avoiding clinical medicine in other diseases]]''' | ||
{{tp|p=32339092|t=2020. Decreased Influenza Incidence under COVID-19 Control Measures, Singapore |pdf=|usr=}} | {{tp|p=32339092|t=2020. Decreased Influenza Incidence under COVID-19 Control Measures, Singapore |pdf=|usr=}} | ||
{{tp|p=32339091|t=2020. Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan |pdf=|usr=}} | {{tp|p=32339091|t=2020. Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan |pdf=|usr=}} | ||
− | + | {{tp|p=32297932|t=ä. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage |pdf=|usr=}} | |
+ | {{tp|p=32348457|t=ä. Where have the STEMIs gone during COVID-19 lockdown?|pdf=|usr=}} | ||
*'''[[Occupational medicine, workplace security and status hygienicus]]''' | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | ||
Zeile 155: | Zeile 211: | ||
* | * | ||
*'''[[Host, vector, one health, atmospheric aspects]]''' | *'''[[Host, vector, one health, atmospheric aspects]]''' | ||
+ | {{tp|p=C7151430|t=ä. Airborne transmission of SARS-CoV-2: the world should face the reality |pdf=|usr=}} | ||
+ | {{tp|p=32363409|t=2020. SARS-CoV-2 spread in Northern Italy: what about the pollution role?|pdf=|usr=}} | ||
+ | {{tp|p=32283458|t=2020. COVID-19 as a factor influencing air pollution?|pdf=|usr=}} | ||
+ | {{tp|p=32268945|t=ä. Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy?? |pdf=|usr=}} | ||
+ | {{tp|p=32361082|t=2020. Food safety issues related to wildlife have not been taken seriously from SARS to COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32353790|t=2020. Biomass use and COVID-19: A novel concern |pdf=|usr=}} | ||
+ | {{tp|p=32330766|t=ä. Is temperature reducing the transmission of COVID-19 ?|pdf=|usr=}} | ||
+ | {{tp|p=32202420|t=ä. An Imperative Need for Research on the Role of Environmental Factors in Transmission of Novel Coronavirus (COVID-19) |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
*'''[[Origin of Covid19]]''' | *'''[[Origin of Covid19]]''' | ||
{{tp|p=32315281|t=2020. Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}} | {{tp|p=32315281|t=2020. Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}} | ||
Zeile 167: | Zeile 236: | ||
*'''[[Epidemiology]]''' | *'''[[Epidemiology]]''' | ||
+ | {{tp|p=32323978|t=ä. Letter to the Editor: Wastewater-Based Epidemiology Can Overcome Representativeness and Stigma Issues Related to COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32202421|t=ä. Can a Paper-Based Device Trace COVID-19 Sources with Wastewater-Based Epidemiology?|pdf=|usr=}} | ||
+ | {{tp|p=32311865|t=2020. Prevention of exposure and dispersion of COVID-19 using air purifiers: challenges and concerns |pdf=|usr=}} | ||
+ | {{tp|p=32375455|t=2020. Prediction of COVID-19 transmission dynamics using a mathematical model considering behavior changes in Korea |pdf=|usr=}} | ||
+ | {{tp|p=32345002|t=2020. Joint Statement of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on the response to the COVID-19 outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32345000|t=2020. Urgent appeal to minimize community health impacts of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32345001|t=2020. Recommendations to the government following the declaration of COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32344999|t=2020. Preparedness and response to community spread of COVID-19 governmental and national recommendations for COVID-19 by the Pan-Academic Action Committee |pdf=|usr=}} | ||
+ | {{tp|p=32344998|t=2020. Joint Statement of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on the response to the COVID-19 outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32344997|t=2020. Professional academic organizations on infectious disease Joint Statement on COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32192278|t=2020. WHO International Health Regulations Emergency Committee for the COVID-19 outbreak |pdf=|usr=}} | ||
+ | {{tp|p=32164053|t=2020. Estimating the reproductive number and the outbreak size of COVID-19 in Korea |pdf=|usr=}} | ||
+ | {{tp|p=32035431|t=2020. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea |pdf=|usr=}} | ||
+ | {{tp|p=32023775|t=2020. An interim review of the epidemiological characteristics of 2019 novel coronavirus |pdf=|usr=}} | ||
+ | {{tp|p=32202489|t=ä. Risk of COVID-19 importation to the Pacific islands through global air travel |pdf=|usr=}} | ||
+ | {{tp|p=32100667|t=ä. Passengers destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America |pdf=|usr=}} | ||
+ | {{tp|p=32242790|t=ä. The challenges and considerations of community-based preparedness at the onset of COVID-19 outbreak in Iran, 2020 |pdf=|usr=}} | ||
+ | {{tp|p=32373189|t=2020. Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32352515|t=ä. The battle against COVID-19: mortality in Italy |pdf=|usr=}} | ||
+ | {{tp|p=32255475|t=ä. Denominator matters in estimating COVID-19 mortality rates |pdf=|usr=}} | ||
+ | {{tp|p=32255476|t=ä. COVID-19 experience in Bergamo, Italy |pdf=|usr=}} | ||
+ | {{tp|p=32255477|t=ä. Strategies to control COVID-19 and future pandemics in Africa and around the globe |pdf=|usr=}} | ||
+ | {{tp|p=32352314|t=2020. The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions |pdf=|usr=}} | ||
+ | {{tp|p=32347745|t=ä. Ethical aspects of the COVID-19 crisis: How to deal with an overwhelming shortage of acute beds |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | |||
*'''[[Failure of politics and public health guidance]]''' | *'''[[Failure of politics and public health guidance]]''' | ||
Zeile 187: | Zeile 283: | ||
*[[coviki state of development]] | *[[coviki state of development]] | ||
*'''[[misc.]]''' | *'''[[misc.]]''' | ||
+ | {{tp|p=32293675|t=ä. Key words to be adopted for COVID-19 research: A return to simple, large, randomized trials |pdf=|usr=}} | ||
+ | |||
*'''[[from the ads]]''' | *'''[[from the ads]]''' | ||
*[http://www.okaybio.com covid19 antibodies, proteins & reagents] | *[http://www.okaybio.com covid19 antibodies, proteins & reagents] | ||
*[http://www.reactionbiology.com 700 kinsse assays] | *[http://www.reactionbiology.com 700 kinsse assays] |
Version vom 21. Mai 2020, 05:57 Uhr
32335367 ä. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
32142596 2020. Machine Learning, COVID?19 (2019?nCoV), and multi?OMICS
32187834 2020. ..COVID19: Cytometry and the New Challenge for Global Health
32220422 2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections
32271376 ä. Factors associated with prolonged viral RNA shedding in patients with COVID-19
32348472 ä. A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients?
32160148 2020. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China
32343223 2020. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient
32298228 2020. Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19
32334995 2020. Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia
32303472 ä. Acute pulmonary embolism in a patient with COVID-19 pneumonia
32348233 2020. Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease
32227120 ä. Acute pulmonary embolism and COVID-19 pneumonia: a random association?
32338707 ä. Acute pulmonary embolism in conjunction with intramural right ventricular thrombus in a SARS-CoV-2-positive patient
32363381 ä. Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?
32227076 ä. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19
32196087 ä. SARS-CoV2: should inhibitors of the renin?angiotensin system be withdrawn in patients with COVID-19?
32267502 ä. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection
32267494 ä. CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic
32285920 ä. Transient complete heart block in a patient with critical COVID-19
32285915 ä. Typical takotsubo syndrome triggered by SARS-CoV-2 infection
32338706 ä. Myocarditis revealing COVID-19 infection in a young patient
32282027 ä. COVID-19-related myocarditis in a 21-year-old female patient
32283980 2020. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms
32269598 2020. Anosmia and ageusia are emerging as symptoms in patients with COVID-19: What does the current evidence say?
32370982 ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review
32253535 ä. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
32328771 ä. The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19
32303881 ä. Possible link between anosmia and COVID-19: sniffing out the truth
32299479 2020. Acute kidney injury in SARS-CoV-2 infected patients
32197060 2020. Rhabdomyolysis as Potential Late Complication Associated with COVID-19
32294179 ä. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications
32293672 ä. Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
32215622 ä. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility
32378471 2020. Animal models for emerging coronavirus: progress and new insights
31859605 2020. Genetic manipulation of porcine deltacoronavirus reveals insights into NS6 and NS7 functions: a novel strategy for vaccine design
32294704 ä. Structured thoracic computed tomography report for COVID-19 pandemic
32374802 ä. The halo sign as a chest computed tomography finding of COVID-19
32241244 2020. Diagnostic value and key features of computed tomography in Coronavirus Disease 2019
32285222 ä. Three unsuspected CT diagnoses of COVID-19
32285028 2020. Lung Changes on Chest CT During 2019 Novel Coronavirus (COVID-19) Pneumonia
32276598 2020. Using echocardiography to guide the treatment of novel coronavirus pneumonia
32306118 ä. COVID-19 in otolaryngologist practice: a review of current knowledge
32352517 ä. Anticoagulation in COVID-19
32371555 2020. Utility of extracorporeal membrane oxygenation in COVID-19
32357995 2020. Tracheal intubation in patients with COVID-19
32326959 2020. High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients
C7156900 2020. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series
32322959 ä. Tracheostomy in the COVID-19 pandemic
32314050 ä. Recommendation of a practical guideline for safe tracheostomy during the COVID-19 pandemic
32232395 ä. Initial COVID-19 affecting cardiac patients in China
32324223 ä. Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence
32324222 ä. Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19
32236478 ä. Speculation is not evidence: antihypertensive therapy and COVID-19
32286607 ä. Might renin?angiotensin system blockers play a role in the COVID-19 pandemic?
32344292 2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
32305831 ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment
32241316 ä. Case Report on Early Diagnosis of COVID-19
32343659 2020. A Moderate Case of COVID-19 Viral Pneumonia During the SARS-CoV-2 Pandemic
32160149 2020. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States
32337324 2020. The Data set for Patient Information Based Algorithm to Predict Mortality Cause by COVID-19
32267826 2020. Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand
32208917 2020. The different clinical characteristics of corona virus disease cases between children and their families in China ? the character of children with COVID-19
C7102592 ä. Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID)
32363880 2020. Medical treatment options for COVID-19
32372695 2020. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol
32347925 ä. Statin therapy in COVID-19 infection
32347923 ä. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety
32337546 ä. Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?
32282032 ä. Neprilysin inhibitor?angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients
32241022 ä. SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection
32297915 ä. Comment of the potential risks of sexual and vertical transmission of Covid-19 infection
32243255 2020. Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations
32342724 2020. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient
32324531 2020. The Practice of Wearing Surgical Masks during the COVID-19 Pandemic
32284092 2020. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols
32282025 ä. Donning and doffing of personal protective equipment (PPE) for angiography during the COVID-19 crisis
32228737 ä. COVID-19 disease emergency operational instructions for Mental Health Departments issued by the Italian Society of Epidemiological Psychiatry
32303485 ä. French consensus on management of head and neck cancer surgery during COVID-19 pandemic
32338298 ä. The After Diagnosis Head and Neck cancer-specific Patient Concerns Inventory (HaNC-AD) as a pre-treatment preparation aid during the COVID-19 pandemic
32232396 ä. Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak
32361812 ä. Mental health treatment online during the COVID-19 outbreak
32338764 ä. A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience
32286606 ä. Priorities for Cath labs in the COVID-19 tsunami: Roberto Ferrari and co-authors present a procedure to follow subsequent to the outbreak in Italy
32320040 ä. Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective
32242891 ä. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel
32285027 2020. Breast Cancer Diagnosis, Treatment and Follow-Up During COVID-19 Pandemic
32285026 2020. Sars-CoV-2 (COVID-19) Outbreak and Breast Cancer Surgery in Turkey
32305011 2020. Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)?related disease pandemic
32294611 2020. A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19?positive patients with cancer
32342698 ä. Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic
32363492 ä. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19
32339092 2020. Decreased Influenza Incidence under COVID-19 Control Measures, Singapore
32339091 2020. Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan
32297932 ä. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage
32348457 ä. Where have the STEMIs gone during COVID-19 lockdown?
- Occupational medicine, workplace security and status hygienicus
- Economic aspects of the status hygienicus
- Educational aspects of the status hygienicus
- Host, vector, one health, atmospheric aspects
C7151430 ä. Airborne transmission of SARS-CoV-2: the world should face the reality
32363409 2020. SARS-CoV-2 spread in Northern Italy: what about the pollution role?
32283458 2020. COVID-19 as a factor influencing air pollution?
32268945 ä. Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy??
32361082 2020. Food safety issues related to wildlife have not been taken seriously from SARS to COVID-19
32353790 2020. Biomass use and COVID-19: A novel concern
32330766 ä. Is temperature reducing the transmission of COVID-19 ?
32202420 ä. An Imperative Need for Research on the Role of Environmental Factors in Transmission of Novel Coronavirus (COVID-19)
32315281 2020. Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2
32315626 2020. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
32148173 2020. Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination
32102621 2020. No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2
32056509 2020. HIV-1 did not contribute to the 2019-nCoV genome
32323978 ä. Letter to the Editor: Wastewater-Based Epidemiology Can Overcome Representativeness and Stigma Issues Related to COVID-19
32202421 ä. Can a Paper-Based Device Trace COVID-19 Sources with Wastewater-Based Epidemiology?
32311865 2020. Prevention of exposure and dispersion of COVID-19 using air purifiers: challenges and concerns
32375455 2020. Prediction of COVID-19 transmission dynamics using a mathematical model considering behavior changes in Korea
32345002 2020. Joint Statement of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on the response to the COVID-19 outbreak
32345000 2020. Urgent appeal to minimize community health impacts of COVID-19
32345001 2020. Recommendations to the government following the declaration of COVID-19 pandemic
32344999 2020. Preparedness and response to community spread of COVID-19 governmental and national recommendations for COVID-19 by the Pan-Academic Action Committee
32344998 2020. Joint Statement of the Korean Society for Preventive Medicine and the Korean Society of Epidemiology on the response to the COVID-19 outbreak
32344997 2020. Professional academic organizations on infectious disease Joint Statement on COVID-19
32192278 2020. WHO International Health Regulations Emergency Committee for the COVID-19 outbreak
32164053 2020. Estimating the reproductive number and the outbreak size of COVID-19 in Korea
32035431 2020. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea
32023775 2020. An interim review of the epidemiological characteristics of 2019 novel coronavirus
32202489 ä. Risk of COVID-19 importation to the Pacific islands through global air travel
32100667 ä. Passengers destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America
32242790 ä. The challenges and considerations of community-based preparedness at the onset of COVID-19 outbreak in Iran, 2020
32373189 2020. Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic
32352515 ä. The battle against COVID-19: mortality in Italy
32255475 ä. Denominator matters in estimating COVID-19 mortality rates
32255476 ä. COVID-19 experience in Bergamo, Italy
32255477 ä. Strategies to control COVID-19 and future pandemics in Africa and around the globe
32352314 2020. The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions
32347745 ä. Ethical aspects of the COVID-19 crisis: How to deal with an overwhelming shortage of acute beds
32246996 ä. The SARS-CoV-2 epidemic: how the Italian public is being informed
32292239 2020. Unpacking the black box: How to promote citizen engagement through government social media during the COVID-19 crisis
32252845 ä. Adaptation of the National Plan for the Prevention and Fight Against Pandemic Influenza to the 2020 COVID-19 Epidemic in France
C7152572 ä. Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter
32241328 ä. Limited Early Warnings and Public Attention to Coronavirus Disease 2019 in China, January?February, 2020: A Longitudinal Cohort of Randomly Sampled Weibo Users
- Lost people
- Lost civilization
- History of covid19 exploration
- Current state of coviki.org
- PubMed selected papers unsorted to be listed in contents topics
- coviki state of development
- misc.
32293675 ä. Key words to be adopted for COVID-19 research: A return to simple, large, randomized trials